Your Article Summary
See Latest ArticlesClinical Application of Cordyceps sinensis on Immunosuppressive Therapy in Renal Transplantation
Transplantation Proceedings, 06/25/09
Li Y et al. - The use of CS may allow decreased dosages and concentrations of CsA causing fewer side effects without an increased risk of acute rejection. In addition, CS with reduced dose CsA may decrease proteinuria and retard CAN progression.
Related Articles
Using Complementary and Alternative Medicines to Target the Host Response during Severe Influenza
Evidence-based Complementary and Alternative Medicine, 10/05/09
Relevance Score: 39%
Today in Transplantation...keeping you current
Receive free subspecialty "5-minute updates" via email
Long-term mycophenolate mofetil treatment in pediatric renal transplant patients
Dialysis & Transplantation, 12/02/09
Determinants of Resistive Index Shortly after Transplantation: Independent Relationship with Delayed Graft Function
Nephron: Clinical Practice, 12/02/09
Successful Renal Transplantation in Factor H Autoantibody Associated HUS with CFHR1 and 3 Deficiency and CFH Variant G2850T
American Journal of Transplantation, 12/02/09